Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth

Am J Obstet Gynecol. 2006 Nov;195(5):1249-53. doi: 10.1016/j.ajog.2006.09.002.

Abstract

Objective: This study was undertaken to determine whether the interleukin-1 receptor antagonist (IL-1RN) variable number tandem repeat polymorphism is associated with preterm birth.

Study design: A case-control study was performed. Cases (n = 95) delivered before 37 weeks after preterm labor (PTL) or preterm premature rupture of membranes (PPROM) and controls (n = 105) delivered after 37 weeks. Maternal DNA was genotyped by polymerase chain reaction for a length polymorphism in intron 2 of the IL-1RN gene.

Results: There was no significant difference in maternal age, ethnicity, insurance status, or parity between groups. Allele and genotype frequencies did not differ significantly from that expected under Hardy-Weinberg equilibrium (P = .59) in the total group as well as study groups. Of the 95 cases, 26.8% had at least 1 copy of allele 2 present compared with 12.4% in the control group (P < .0004).

Conclusion: Maternal carriage of at least 1 copy of the IL-1RN allele 2 appears to be associated with increased risk of preterm birth.

MeSH terms

  • Adult
  • Alleles
  • Case-Control Studies
  • Female
  • Gene Dosage
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / genetics*
  • Introns / genetics*
  • Polymorphism, Genetic*
  • Pregnancy / genetics*
  • Premature Birth / genetics*
  • Tandem Repeat Sequences

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein